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Helicobacter cinaedi infection is rarely encountered in nonimmunocompromised patients. We report the case of an 85-
year-old man who presented with axillobifemoral bypass graft infection caused by Helicobacter cinaedi. The patient
was not immunocompromised. We successfully treated him by iliac stenting of the native iliac artery, with near-total
removal of the infected graft. At present, 48 months later, the patient is doing well at home, with no evidence of
infection. To the best of our knowledge, this is the ﬁrst report of infection of a prosthetic graft caused by Helicobacter
cinaedi. (J Vasc Surg 2015;61:231-3.)Helicobactor cinaedi is a Gram-negative spiral bacillus
that inhabits the intestinal tract of mammals and is known
to cause gastroenteritis and bacteremia, particularly in
immunocompromised individuals.1,2 However, there has
been no report of infection of a prosthetic graft caused
by Helicobacter cinaedi. We successfully treated the
axillobifemoral bypass (AFB) graft infection caused by Hel-
icobacter cinaedi by percutaneous transluminal angioplasty
and removal of the infected graft.CASE REPORT
An 85-year-old man presented with fever, pain, and swelling
in the left anterior chest region. He had a past medical history of
atrial ﬁbrillation, dilated cardiomyopathy, chronic obstructive
pulmonary disease, and arteriosclerotic occlusive disease with total
occlusion of the left common iliac artery and severe stenosis of the
right external iliac artery. In 1999, left AFB with a Dacron graft
had been performed at another hospital. Postoperative noninfected
lymphorrhea in the right groin had necessitated debridement and
ligation of the lymph duct on three occasions at 2, 3, and 4 weeks
after the surgery, respectively. He had remained healthy for the
next 10 years until the current episode. In March 2009, he noticed
a swelling around the left anterior chest region accompanied by
fever, and graft infection was suspected. Initially, he respondedFig 1. Patient appearance. The arrow indicating swelling and
redness around the left anterior chest region of the patient.
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the symptoms recurred, and the patient was referred to us.
At presentation, examination revealed swelling and redness
around his left breast region just above the site of the previous
AFB graft (Fig 1). The patient showed no evidence of231
Fig 2. Computed tomography angiography showing perigraft
ﬂuid collection. The arrow indicating patent prosthetic graft.
Fig 3. A, Prestenting digital subtraction angiography (right
arrow indicates occlusion of native external iliac artery. B, P
artery). The arrow indicates total occlusion of native comm
ography demonstrates perfect recanalization of common and
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sented with a history of left breast pain and low-grade fever, and
his serum total protein was 7.7 g/dL (albumin 3.4 g/dL). His
white blood cell count was 9100/mL, and the serum C-reactive
protein was 16.09 mg/dL. Computed tomography angiography
revealed perigraft ﬂuid collection suggestive of graft infection
(Fig 2). Repeated culture of the abscess ﬂuid revealed Helicobacter
cinaedi, which showed broad sensitivity to many antibiotics. On
the other hand, the result of the blood culture was negative. The
ankle-brachial index (ABI) was 0.73 on the right side and 0.88
on the left side. He had no symptoms of leg ischemia. Administra-
tion of cefozopran (1 gram twice per day) was started.
Since the patient was of advanced age and had the comorbid-
ities of dilated cardiomyopathy and chronic obstructive pulmonary
disease, the minimally invasive approach of endovascular treatment
was planned. A 6F sheath was inserted in the native common
femoral artery of both sides, which were at a sufﬁcient distance
from the previous graft anastomoses. The right external iliac artery
and left common iliac artery were totally occluded (Fig 3, A, B).
Initially, percutaneous balloon angioplasty was carried out through
a bifemoral approach. Because of dense calciﬁcation, a 10- 
60-mm self-expanding Smart stent (Cordis Co, Bridgewater, NJ)femoral artery). The asterisk indicates Dacron graft; the
restenting digital subtraction angiography (left femoral
on iliac artery. C, Poststenting digital subtraction angi-
external iliac artery.
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a similar 10-  60-mm stent was deployed originating in the left
common iliac artery into the external iliac artery (Fig 3, C). Post-
operatively, the ABI improved slightly to 0.78 on the right side
and to 0.97 on the left side. We waited for 1 week postoperatively
to ensure the absence of any problems with the iliac stenting
including stent fracture and stent infection. Subsequently, under
general anesthesia, excision of the infected graft and debridement
around the perigraft ﬂuid were performed. Only the remnant of
anastomoses sites was left because graft infection was extremely
localized, and the blood culture was negative. The dense granula-
tion tissue surrounding the graft was also resected. Primary closure
of the wound was carried out with insertion of a drainage tube.
The postoperative course was uneventful. The drainage tube was
removed after the ﬁrst postoperative culture was reported negative
on the third postoperative day. Oral administration of sulbactam/
ampicillin was continued for 2 weeks after the patient was dis-
charged. Postoperative computed tomography angiography
revealed successful revascularization. The ABI remained at the
same level without any symptoms of leg ischemia. Forty-eight
months later, the patient is doing well at home, with no evidence
of infection.
DISCUSSION
Prosthetic graft infection is a rare complication of
bypass procedures, occurring at an estimated incidence of
0.6% to 3.0%3,4; however, it is a severe complication asso-
ciated with a high mortality rate.5 Calligaro et al, in their
99 patients presenting with early graft infection, reported
a predominance of Staphylococcus aureus (35%) and entero-
bacteria (33%), followed by Streptococcus sp. (27%),
S. epidermidis (19%), and Pseudomonas sp. (16%).6 On
the other hand, in a series of 42 patients presenting with
late graft infection, while the rate of infection by S. aureus
was 85%, and that by S. epidermidis was 38%, the infection
rate by enterobacteria was 40.5% and that by Pseudomonas
sp. was 26%. Infection by enterococci and Gram-negative
bacilli is rare. There is no report to date of graft infection
caused by Helicobactor cinaedi.
Helicobactor cinaedi is a Gram-negative spiral bacillus
that inhabits the intestinal tract of humans and has
a wide range of reservoirs. It is well known to cause diar-
rhea as well as bacteremia, cellulitis, and other symptoms
after gaining entry into the body through the intestinal
mucosa.1,2 Although these conditions are primarily
observed in HIV-infected patients, their occurrence among
other immunocompromised patients and patients with
renal or hepatic diseases has also been reported recently.7
However, Helicobacter cinaedi infection is rare in nonim-
munocompromised patients. In this case, the patient
showed no evidence of immunocompromise, or any
evidence of malnutrition. Therefore, the actual source ofthe bacteria that caused the current graft infection
remained unclear.
Regarding surgical treatment of infected grafts, the
traditional standard approach is complete debridement of
the infected tissues, complete resection of the prosthesis
and adjacent arterial area, and maintenance or restoration
of the arterial continuity with an in situ or extra-anatomic
reconstruction using a biological graft or prosthesis.
However, with the aging society, the number of patients
with comorbidities is increasing. Conventional open
surgery may be invasive and is frequently not tolerated by
such patients. Recently, there has been a paradigm shift
in the management of arterial occlusive disease to the
endovascular approach, with good clinical outcomes.8-10
In the past few years, multiple centers worldwide have
begun to perform balloon angioplasty and vascular stenting
as an alternative to surgical revascularization for iliac arterial
occlusive disease in high-risk patients.11 The procedure is
relatively straightforward, simple, and minimally invasive.
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